1 |
Homsy, W., Lefebvre, M., Caille, G., and du Souich, P., Metabolism of diltiazem in hepatic and extrahepatic tissues of rabbits. Pharm. Res., 12,609-614 (1995)
DOI
ScienceOn
|
2 |
Johnson, L. M., Lankford, S. M., and Bai, S. A., The influence of cimetidine on the pharmacokinetics of the enantiomers of verapamil in the dog during multiple oral dosing. J. Vet. Pharmacal. Ther., 18, 117-123 (1995)
DOI
ScienceOn
|
3 |
Mikus, G., Eichelbaum, M., Fischer, C., Gumulka, S., Klotz, U., and Kroemer, H. K., Interaction of verapamil and cimetidine: stereochemical aspects of drug metabolism, drug disposition and drug action. J. Pharmacal. Exp. Ther., 253, 1042-1048 (1990)
|
4 |
Sakuma, M., Yoshikawa, M., and Sato, Y., The whole body autoradiographic studies on the disposition of 14C-labeled new 1,5-benzothiazepine derivative (14C-CRD-401) in mice. Chem. Pharm. Bull., 19,995-1005 (1971)
DOI
PUBMED
ScienceOn
|
5 |
Sterzel, P. B., Renal actions of calcium antagonists. J. Cardiovasc. Pharmacol., 10, 17-22 (1987)
DOI
|
6 |
Winship, L. C., McKenney, J. M., and Wright, J. T., The effect of ranitidine and cimetidine on single-dose diltiazem pharma-cokinetics. Pharmacotherapy, 5,16-19 (1985)
PUBMED
|
7 |
Smith, M. S., Benyunes, M. C., Bjornsson, T. D., Shand, D. G., and Pritchett, E. L., Influence of cimetidine on verapamil kinetics and dynamics. Clin. Pharmacol. Ther., 36, 551-554 (1984)
DOI
ScienceOn
|
8 |
Yamaoka, K., Tanigawara, Y., Nakagawa. T., and Uno, T., A pharmacokinetics analysis program for microcomputer. J. Pharm. Dyn., 4, 879-883 (1971)
|
9 |
Sutton, D., Butler, A. M., Nadin, L., and Murray, M. L., Role of CYP3A4 in human hepatic diltiazem N-demethylation: in-hibition of CYP3A4 activity by oxidized diltiazem metabolite. J. Pharmacal. Exp. Ther., 282, 294-300 (1994)
|
10 |
Scholz, H., Pharmacological aspects of calcium channel blockers. Cardiovasc. Drugs Ther., 10,869-872 (1997)
DOI
ScienceOn
|
11 |
Hermann, P., Rodger, S. D., Remones, G., Thenot, J. P., London, D. R., and Morselli, P. L., Pharmcokinetics of diltiazem after intravenous and oral administration. Eur. J. Clin. Pharmacol., 24, 349-352 (1983)
DOI
ScienceOn
|
12 |
Murray, M. and Butler, A. M., Enhanced inhibition of microsomal cytochrome p450 in rat liver during diltiazem biotransforma-tion. J. Pharmcol. Exp. Ther., 279,1447-1452 (1996)
|
13 |
Ruilope, L. M. and Alcazar, J. M., Renal effects of calcium entry blockers. Cardiovasc. Drugs Ther., 4,979-982 (1990)
DOI
|
14 |
Schwartz, J. B., Upton, R. A., Lin, E. T., Williams, R. L., and Benet, L. Z., Effect of cimetidine or ranitidine administration on nifedipine pharmacokinetics and pharmacodynamics. Clin. Pharmacol. Ther., 43, 673-680 (1998)
DOI
ScienceOn
|
15 |
Choi, J. S. and Burm, J. P., Pharmacokinetics of diltiazem and deacetyldiltiazem after intravenous administration of diltiazem in mild and medium folate-induced renal failure rabbits. Kor. J. Clin. Pharm., 10, 120-124 (2000)
|
16 |
Choi, J. S. and Burm, J. P., Pahrmacokinetics of dilitiazem and its main metabolite, deacetyldiltiazem after oral administration of diltiazem in mild and medium folate-induced renal failure rabbits. Arch. Pharm. Res., 24, 333-337 (2001)
DOI
ScienceOn
|
17 |
Bianchetti, G., Regazzi, M., Rondanelli, R., Ascalone, V., and Morselli, P. L., Bioavailabiltity of diltiazem as a function of the administered dose. Biopharm. Drug Dispas., 12, 391-401 (1991)
DOI
ScienceOn
|
18 |
Khan, A., Langley, S. J., Mullins, F. G., Dixon, J. S., and Toon, S., The pharmacokinetics and pharmacodynamics of nifedipine at steady state during concomitant administration of cimetidine or high dose ranitidine. Br. J. Clin. Pharmacol., 32,519-522 (1991)
DOI
ScienceOn
|
19 |
Epstein, M. and Loutzenhiser, R. D., Effects of calcium an-tagonists on renal hemodynamics. Am. J. Kidney Dis., 16, 10-14 (1990)
|
20 |
eboeuf, F. and Grech-Belanger, O. L., Deacetylation of diltiazem by rat liver. Drug Metab. Dispos., 15, 122-126(1987)
|
21 |
Knodell, R. G., Browne, D. G., Gwozdz, G. P., Brian, W. R, and Guengerich F. P., Differential inhibition of individual human liver cytochromes P-450 by cimetidine. Gastroenterology, 101, 1680-1691 (1991)
PUBMED
|
22 |
Goebel, K. J. and Kolle, E. U., High performance liquid chromatographic dertermination of diltiazem and four of its metabolites in plasma. J. Chromatogr., 345, 355-363 (1985)
DOI
PUBMED
ScienceOn
|
23 |
Eichelbaum, M. and Echizen, H., Clinical pharmacology of calcium antagonists. J. Cardiovasc. Pharmacol., 6, 963-967 (1984)
DOI
|
24 |
Kirch, W., Ramsch, K., Janisch, H. D., and Ohnhaus, E. E., The influence of two histamine H2-receptor antagonists, cimeti-dine and ranitidine, on the plasma levels and clinical effect of nifedipine and metoprolol. Arch. Toxicol. Suppl., 7, 256-259 (1984)
DOI
|